Hepatocellular Carcinoma News and Research

RSS
Exome sequencing helps identify link between environmental exposures and mutational patterns in HCC

Exome sequencing helps identify link between environmental exposures and mutational patterns in HCC

Long-term ETV or TDF therapy improves survival rate for Caucasian patients with CHB

Long-term ETV or TDF therapy improves survival rate for Caucasian patients with CHB

Can-Fite seeks EMA Orphan Drug Designation for CF102 in HCC

Can-Fite seeks EMA Orphan Drug Designation for CF102 in HCC

No effect of baseline cirrhosis on long-term TDF treatment outcomes

No effect of baseline cirrhosis on long-term TDF treatment outcomes

Delcath expands global Phase 2 program to treat hepatocellular carcinoma

Delcath expands global Phase 2 program to treat hepatocellular carcinoma

NASH patients more likely to have increased intestinal permeability, shows study

NASH patients more likely to have increased intestinal permeability, shows study

CASI receives CFDA approval for ENMD-2076 Phase 2 clinical trial in ovarian clear cell carcinoma

CASI receives CFDA approval for ENMD-2076 Phase 2 clinical trial in ovarian clear cell carcinoma

CASI initiates ENMD-2076 Phase 2 trial in Chinese patients with triple-negative breast cancer

CASI initiates ENMD-2076 Phase 2 trial in Chinese patients with triple-negative breast cancer

Long-term entecavir, TDF effective in chronic HBV in real-world setting

Long-term entecavir, TDF effective in chronic HBV in real-world setting

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

Regulus Therapeutics reports net loss of $22.2 million for fourth quarter 2014

Regulus Therapeutics reports net loss of $22.2 million for fourth quarter 2014

Researchers develop novel strategy in fight against cancer

Researchers develop novel strategy in fight against cancer

Regulus Therapeutics reports top-line results from RG-101 clinical study for HCV treatment

Regulus Therapeutics reports top-line results from RG-101 clinical study for HCV treatment

Scientists identify gene mutations that provide better insight into hepatitis-liver cancer link

Scientists identify gene mutations that provide better insight into hepatitis-liver cancer link

Age and HBsAg level predict NA-induced HBeAg seroconversion durability

Age and HBsAg level predict NA-induced HBeAg seroconversion durability

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

Using breath tests to diagnose liver diseases: an interview with Larry Cohen

Researchers examine how terpenes can inhibit growth of liver cancer cells

Researchers examine how terpenes can inhibit growth of liver cancer cells

GenSpera reports encouraging results from mipsagargin Phase II study for HCC treatment

GenSpera reports encouraging results from mipsagargin Phase II study for HCC treatment

Mirati begins dosage in MGCD265 Phase 1b clinical trial for NSCLC

Mirati begins dosage in MGCD265 Phase 1b clinical trial for NSCLC

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.